The Positron Emission Tomography (PET) industry trends over the past 18 months have been shaped by strategic collaborations, technological innovation, and regulatory advancements. In 2023, Siemens Healthineers acquired Qonvo, a U.S.-based AI software company, to enhance PET/MRI workflow automation, reflecting a growing emphasis on AI-driven diagnostics. Meanwhile, Lantheus Medical Imaging partnered with Toshiba Pharma to co-develop novel radiopharmaceuticals for oncology, expanding access to precision-targeted PET tracers. Regulatory momentum has accelerated, with the FDA fast-tracking approvals for PET-CT systems incorporating time-of-flight technology, improving imaging accuracy and reducing scan times. The market also witnessed a surge in hybrid imaging solutions, such as GE HealthCare’s launch of its Discovery MI Hybrid PET/CT system, which integrates machine learning for enhanced metabolic analysis. Enterprise trends highlight a shift toward decentralized imaging networks, driven by hospital systems adopting mobile PET units to address rural healthcare gaps. Furthermore, venture capital funding for PET radiotracer startups rose by 40% in 2024, with Mologic securing $60 million to scale its Alzheimer’s disease detection platform, underscoring investor confidence in PET’s role in neurodegenerative diagnostics.
